Molecular subtypes of intrahepatic cholangiocarcinoma
Top Cited Papers
Open Access
- 15 February 2025
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 31 (8) , 755-769
Abstract
No abstract availableKeywords
Funding Information
- Hector Stiftung II
- Hector Stiftung
- China Scholarship Council (201908080072, 202108320069)
This publication has 77 references indexed in Scilit:
- Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract CancerJAMA Oncology, 2023
- Genetic Determinants of Outcome in Intrahepatic CholangiocarcinomaHepatology, 2021
- Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing PatternsThe Oncologist, 2021
- Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studiesInternational Journal of Cancer, 2020
- DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtypeVirchows Archiv, 2019
- Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypesHepatology, 2012
- A smac mimetic reduces TNF Related Apoptosis Inducing Ligand (TRAIL)‐induced invasion and metastasis of cholangiocarcinoma cells†Hepatology, 2010
- Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infectionHepatology, 2008
- A novel “patient‐like” model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines†‡Hepatology, 2007
- Risk factors for intrahepatic cholangiocarcinoma in a low‐risk population: A nationwide case‐control studyInternational Journal of Cancer, 2006